In both trials, there was no reduction in survival with intermittent therapy, but the results of OPTIMOX-2 showed a trend towards improved survival with maintenance fluorouracil during oxaliplatin breaks [ 21 , 22 ].
← all excerpts
Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients.
1
—
—